Ascorbic acid 100mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Ascorbic acid

Available from:

Ennogen Pharma Ltd

ATC code:

A11GA01

INN (International Name):

Ascorbic acid

Dosage:

100mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 09060301

Patient Information leaflet

F.TO STESO 140X340 MM - F.TO PIEGATO 140X28
F.TO STESO 140X340 MM - F.TO PIEGATO 140X28
PACKAGE LEAFLET: INFORMATION FOR THE USER
Ascorbic Acid 500mg, 200mg,
100mg and 50mg Tablets
(Ascorbic acid)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE
YOU START TAKING THIS MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
!
Keep this leaflet. You may need to read
it again.
!
If you have any further questions, ask
your doctor or pharmacist.
!
This medicine has been prescribed for
you only. Do not pass it on to others. It
may harm them, even if their signs of
illness are the same as yours.
!
If you get any side effects, talk to your
doctor or pharmacist. This includes any
possible side effects not listed in this
leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Ascorbic Acid Tablets are and
what they are used for
2.
What you need to know before you take
Ascorbic Acid Tablets
3.
How to take Ascorbic Acid Tablets
4.
Possible side effects
5.
How to store Ascorbic Acid Tablets
6.
Contents
of
the
pack
and
other
information
Ascorbic
Acid
Tablets
contain
ascorbic
acid. Ascorbic acid is a form of vitamin C. It
is used as a supplement for the prevention
and treatment of scurvy.
DO NOT TAKE ASCORBIC ACID TABLETS IF:
!
You are allergic to Ascorbic Acid or any
of the other ingredients of this medicine
(listed in section 6).
!
You
suffer
from
hyperoxaluria
(excretion
of
urine
containing
large
amounts of calcium oxalate crystals).
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before
taking Ascorbic Acid Tablets:
!
If you are to undergo any blood or urine
tests as ascorbic acid can interfere with
some blood and urine tests.
!
If you are a regular smoker.
!
If you have kidney failure as ascorbic
acid enhances aluminium absorption
(present in antacids) which may reach
toxic levels.
OTHER
MEDICINES
AND
ASCORBIC
ACID
TABLETS
Tell your doctor or pharmacist if you are
taking, have recently taken or might take
any other medicines.
This is particularly important if you are
taking any of the following:
!
Amphetamines.
!
Co

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ascorbic Acid 100mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 100mg of ascorbic acid.
Excipient(s) with known effect
Lactose monohydrate
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Tablet.
White to off-white convex tablets.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Prevention and treatment of scurvy.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults and children over 6 years: _
Prophylactic:
25 – 75 mg daily.
Therapeutic:
Not less than 250mg daily in divided doses. Maximum of
1000mg daily.
_Children under 6 years: _
This unit dosage form is unsuitable for children under 6 years.
_Elderly: _As for other adults. As the dietary intake of vitamin C may
be less in
the elderly, they have greater risk of presenting with vitamin C
deficiency.
Method of administration
For oral administration.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in
section 6.1.
Ascorbic acid should not be given to patients with hyperoxaluria.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Increased intake of ascorbic acid over a prolonged period may result
in an
increased renal clearance of ascorbic acid, and deficiency may result
if the
intake is reduced or withdrawn rapidly (see section 4.8).
Interference with serological testing
Ascorbic acid may interfere with tests and assays for urinary glucose,
giving
false-negative results with methods utilising glucose oxidase with
indicator
(e.g. Labstix, Tes-Tape) and false-positive results with neocuproine
methods.
Estimation of uric acid by phosphotungstate or uricase with copper
reduction
and measurement of creatinine in non-deproteinised serum may also be
affected.
High doses of ascorbic acid may give false-negative readings in faecal
occult
blood tests.
Patients with rare hereditary problems of galactose intolerance, total
lactase
deficiency or glucose-galactose malabsorption should not take this
medicine.